20/20 Biolabs, Inc. Common Stock (AIDX NASDAQ) stock market data APIs
$0.8078
0.05(6.2%)
as of June 5, 2026
Try our APIs with
free plan!
20/20 Biolabs, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. It also operates the Clinical Lab Innovation Axcelerator (CLIAx), a CLIA laboratory for overseas diagnostics start-ups. The company was formerly known as 20/20 GeneSystems, Inc. and changed its name to 20/20 Biolabs, Inc. in March 2025. The company was incorporated in 2000 and is based in Gaithersburg, Maryland.
Prev. Close
0.8078
Open
0.8617
High
0.8949
Low
0.7923
52 wk Range
0.79-50
Market Cap
8 510 K
Shares Outstanding
10 612 K
Revenue
1 845 K
EPS
-0.28
Beta
-0.425
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get 20/20 Biolabs, Inc. Common Stock data using free add-ons & libraries
Get 20/20 Biolabs, Inc. Common Stock Fundamental Data
20/20 Biolabs, Inc. Common Stock Fundamental data includes:
- Net Revenue: 1 845 K
- EBITDA: -3 921 809
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get 20/20 Biolabs, Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-05-20
- EPS/Forecast: -0.1
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
20/20 Biolabs, Inc. Common Stock News
New
Pre-Market Movers: BJDX, PMI, SBFM Drive Momentum
(RTTNews) - Biotech stocks are showing strong pre-market moves this Tuesday, hinting at possible breakout setups. Assessing sentiment and momentum in the premarket sets the tone for a trader's day. ...
20/20 Biolabs Initiates Emergency Lab Testing Plans For Ebola And Hantavirus If Outbreak Arises
(RTTNews) - 20/20 Biolabs, Inc. (AIDX), a diagnostic firm focused on laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, announced that it is developin...
20/20 BioLabs Q1 Revenue Slips; Eyes Q2 Growth From Maryland Firefighter Cancer Screening Program
(RTTNews) - 20/20 BioLabs, Inc. (AIDX) reported its financial results for the first quarter, reflecting a revenue slip for the period ending March 31, 2026. Meanwhile, looking ahead to the second qua...
HEALWELL AI Appoints Brad Porter to Board of Directors
HEALWELL appoints Brad Porter, Chief Commercial Officer of HEALWELL and CEO of Orion Health, to its Board of Directors to strengthen the Company's commercial and strategic expertise. Ian McCrae is ste...
Get 20/20 Biolabs, Inc. Common Stock fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
